# Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/ramucirumab-plus-erlotinib-in-patients-with-untreated-egfr-mutated-advanced-non/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kazuhiko Nakagawa,Edward B. Garon,Takashi Seto,Makoto Nishio,Santiago Ponce Aix,Luis Paz‐Ares,Chao‐Hua Chiu,Keunchil Park,Silvia Novello,Ernest Nadal,Fumio Imamura,Kiyotaka Yoh,Jin‐Yuan Shih,Kwok Hung Au,Denis Moro‐Sibilot,Sotaro Enatsu,Annamaria H. Zimmermann,Bente Frimodt‐Moller,Carla Visseren‐Grul,Martin Reck,Quincy S. Chu,Alexis B. Cortot,Jean-Louis Pujol,Denis Moro‐Sibilot,Elizabeth Fabre,Corinne Lamour,Helge Bischoff,Jens Kollmeier,Martin Reck,Martin Kimmich,Walburga Engel-Riedel,Stefan Hammerschmidt,Wolfgang Schütte,Konstantinos Syrigos,Jcm Ho,Kwok‐Hung Au,Silvia Novello,Andrea Ardizzoni,Giulia Pasello,Vanessa Gregorc,Alessandro Del Conte,Domenico Galetta,Toshiaki Takahashi,Kazuhiko Nakagawa,Makoto Nishio,Kiyotaka Yoh,Takashi Seto,Fumio Imamura,Toru Kumagai,Katsuyuki Hotta,Yasushi Goto,Yukio Hosomi,Hiroshi Sakai,Yuichi Takiguchi,Young Hak Kim,Takayasu Kurata,Hiroyuki Yamaguchi,Haruko Daga,Isamu Okamoto,Miyako Satouchi,Satoshi Ikeda,Kazuo Kasahara,Shinji Atagi,Koichi Azuma,Toru Kumagai,Keisuke Aoe,Toru Kumagai,Keisuke Aoe,Yoshitsugu Horio,Nobuyuki Yamamoto,Hiroshi Tanaka,Satoshi Watanabe,Naoyuki Nogami,Tomohiro Ozaki,Ryo Koyama,Tomonori Hirashima,Hiroyasu Kaneda,Keisuke Tomii,Yuka Fujita,Masahiro Seike,Naoki Nishimura,Terufumi Kato,Masao Ichiki,Hideo Saka,Katsuya Hirano,Yasuharu Nakahara,Shunichi Sugawara,Keunchil Park,Sang‐We Kim,Young Joo Min,Hyun Woo Lee,Jin‐Hyoung Kang,Ho Jung An,Ki Hyeong Lee,Jin-Soo Kim,Gyeong‐Won Lee,Sung Yong Lee,Aurelia Alexandru,Anghel Adrian Udrea,Óscar Juan |
| Citations | 616 |
| DOI | 10.1016/s1470-2045(19)30634-5 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | http://www.journals.elsevier.com/the-lancet-oncology/ |
| OpenAlex ID | https://openalex.org/W2978677918 |
| PMID | 31591063 |
| Type | article |
| Year | 2019 |

## Paper authors

Showing 10 of 11.

- [Silvia Novello](https://scholariq.org/researchers/silvia-novello/)
- [Keunchil Park](https://scholariq.org/researchers/keunchil-park/)
- [Jcm Ho](https://scholariq.org/researchers/jcm-ho/)
- [Denis Moro‐Sibilot](https://scholariq.org/researchers/denis-moro-sibilot/)
- [Nobuyuki Yamamoto](https://scholariq.org/researchers/nobuyuki-yamamoto/)
- [Jin‐Yuan Shih](https://scholariq.org/researchers/jin-yuan-shih/)
- [Kiyotaka Yoh](https://scholariq.org/researchers/kiyotaka-yoh/)
- [Edward B. Garon](https://scholariq.org/researchers/edward-b-garon/)
- [Gee‐Chen Chang](https://scholariq.org/researchers/gee-chen-chang/)
- [Te‐Chun Hsia](https://scholariq.org/researchers/te-chun-hsia/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.